Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesOn Demand: Webinars
Conference Coverage Conference Listing
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story
Subscribe
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
Immunotherapy
LeukemiaLeukemiaLeukemia
Lung CancerLung Cancer
LymphomaLymphomaLymphomaLymphomaLymphoma
Myeloma
Rare CancersRare CancersRare CancersRare Cancers
Sarcoma
Skin CancerSkin Cancer
Thyroid Cancer
Spotlight -
  • Blogs
  • Breast Cancer Webinar Series
  • Cancer Horizons
  • Clinical Trial Corner
  • Heal®
  • Publications
  • Videos
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
Immunotherapy
LeukemiaLeukemiaLeukemia
Lung CancerLung Cancer
LymphomaLymphomaLymphomaLymphomaLymphoma
Myeloma
Rare CancersRare CancersRare CancersRare Cancers
Sarcoma
Skin CancerSkin Cancer
Thyroid Cancer
    • Subscribe
Advertisement

Article

October 17, 2018

Marijuana and Lung Cancer: Exploring the Link

Author(s):

Brielle Benyon

As marijuana use continues to increase across the US – and become legalized in more states – understanding the potential negative health effects is paramount.

As marijuana use continues to increase across the US — and become legalized in more states – understanding the potential negative health effects is paramount. However, any link between smoking marijuana and being diagnosed with lung cancer is still up for discussion, according to research conducted at the David Geffen School of Medicine at UCLA.

“As marijuana smoking prevalence increases in the United States, concern regarding its potential risks to lung health has also risen, given the general similarity in the smoke contents between marijuana and tobacco,” Donald P. Tashkin, M.D., division of Pulmonary and Critical Care Medicine said in his research, which was published in the journal Chest.

Marijuana — which is the second most commonly smoked substance in the US behind tobacco – saw a surge of usage between the years 2014 and 2015, when 12.9 percent of adults reported using it within the last year. In the same time frame, there was an increase in the percentage (from 5.1 percent to 7.6 percent) of individuals who used the substance on a daily or near-daily basis.

This increase has generated some public health concern, especially since marijuana shares some carcinogenic components with tobacco (a leading cause of lung cancer), such as phenols, aldehydes, acrolein and more.

“In view of the similarity in the smoke contents of marijuana and tobacco, the increasing usage of marijuana in our society, particularly on a daily or near-daily basis, raises concern regarding a potential link between marijuana smoking and the well-known deleterious effects of regular tobacco smoking on the lung, particularly regarding increased risks for developing COPD (chronic obstructive pulmonary disease) and lung cancer,” Tashkin wrote.

Tashkin analyzed prior studies to better understand the potential link between marijuana smoking and lung cancer. But overall, no definite conclusion could be reached.

“Several lines of evidence exist both for and against a link between marijuana smoking and lung cancer,” he said.

Evidence that supported the association included the fact that biopsies from frequent marijuana smokers had the same histopathologic epithelial abnormalities that were present in tobacco smokers. This included squamous metaplasia and cellular disorganization, which are believed to be pre-cancerous. Marijuana smokers also presented with higher levels of Ki67 and EGFR, which are the products of oncogenes. Not to mention, marijuana smoke contains benzpyrene, which Tashkin said is a “very potent human carcinogen.”

However, since many people who smoke marijuana also have a history of tobacco smoking, it has been a struggle for researchers to draw a clear line between the two.

Not to mention, previous research has shown that delta-9 tetrahydrocannabinol (THC) — the psychoactive ingredient in marijuana – can have a tumor suppressive effect in the lungs. This effect could counteract any tumor growth that marijuana smoking could promote.

“(T)he weight of evidence from well-designed, epidemiologic studies does not support the concept that habitual marijuana use in the manner and quantity in which it is customarily smoked, when adjusted for tobacco, is a significant risk factor for the development of lung cancer,” Tashkin said, noting the need for more research on the effect marijuana has on lung health.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of 2 doctors and text.
Image of two doctors and text.
Image of man.
Image of doctor.
Image of Dr. Boffa.
Most patients in accredited hospitals had smoking discussions documented, showing key care opportunities and smoking’s impact on treatment outcomes.
Image of Dr. Reznick
There are a number of reasons why patients with cancer are encouraged to enroll in clinical trials, Dr. Michael J. Pishvaian explained.
a man and a woman in front of a dark blue background for CURE Speaking Out
Related Content
Advertisement
Image of two doctors with text.
June 13th 2025

Updates in Shared Decision-Making in Lung Cancer Following ASCO 2025

Ryan Scott
Treating patients with lung cancer always calls for a focus on informed and shared decision-making, according to expert oncologists.
CURE Cancer Horizons logo
February 26th 2024

FDA Approvals from February 2024

Alex Biese Brielle Benyon
February brought in multiple FDA approvals in the oncology space. Here’s an overview of some of the most recent ones.
FDA granted priority review to Zepzelca plus Tecentriq in extensive-stage small cell lung cancer: © stock.adobe.com.
June 11th 2025

FDA Grants Priority Review to Zepzelca Combo for Small Cell Lung Cancer

Spencer Feldman
FDA granted priority review to Zepzelca plus Tecentriq for first-line maintenance in extensive-stage small cell lung cancer.
Guidelines for Childhood Neuroblastoma, FDA Decisions and More
February 12th 2024

Guidelines for Childhood Neuroblastoma, FDA Decisions and More

Alex Biese Brielle Benyon
Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews
Image of lungs.
Published: June 8th 2025 | Updated: June 8th 2025

Detailing the Potential Benefit of Intratumoral Therapies in Lung Cancer

Ryan Scott
Dr. Jared Weiss walks patients through the therapeutic potential viability of intratumoral therapies among those with lung cancer.
image of lungs
June 8th 2025

Targeted Chemo Improves Survival in Early-Stage Lung Cancer

Jordyn Sava
Using a 14-gene test to guide chemotherapy significantly improved disease-free survival in patients with early nonsquamous lung cancer.
Related Content
Advertisement
Image of two doctors with text.
June 13th 2025

Updates in Shared Decision-Making in Lung Cancer Following ASCO 2025

Ryan Scott
Treating patients with lung cancer always calls for a focus on informed and shared decision-making, according to expert oncologists.
CURE Cancer Horizons logo
February 26th 2024

FDA Approvals from February 2024

Alex Biese Brielle Benyon
February brought in multiple FDA approvals in the oncology space. Here’s an overview of some of the most recent ones.
FDA granted priority review to Zepzelca plus Tecentriq in extensive-stage small cell lung cancer: © stock.adobe.com.
June 11th 2025

FDA Grants Priority Review to Zepzelca Combo for Small Cell Lung Cancer

Spencer Feldman
FDA granted priority review to Zepzelca plus Tecentriq for first-line maintenance in extensive-stage small cell lung cancer.
Guidelines for Childhood Neuroblastoma, FDA Decisions and More
February 12th 2024

Guidelines for Childhood Neuroblastoma, FDA Decisions and More

Alex Biese Brielle Benyon
Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews
Image of lungs.
Published: June 8th 2025 | Updated: June 8th 2025

Detailing the Potential Benefit of Intratumoral Therapies in Lung Cancer

Ryan Scott
Dr. Jared Weiss walks patients through the therapeutic potential viability of intratumoral therapies among those with lung cancer.
image of lungs
June 8th 2025

Targeted Chemo Improves Survival in Early-Stage Lung Cancer

Jordyn Sava
Using a 14-gene test to guide chemotherapy significantly improved disease-free survival in patients with early nonsquamous lung cancer.
About Us
Advertise / Support
Editorial Board
Contact Us
CancerNetwork.com
TargetedOnc.com
OncLive.com
OncNursingNews.com
Terms & Conditions
Privacy
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.